𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Failure to demonstrate rat hippocampus adenylate cyclase

✍ Scribed by G. Poeggel; H. -G. Bernstein; H. Luppa

Book ID
104786606
Publisher
Springer
Year
1980
Tongue
English
Weight
299 KB
Volume
65
Category
Article
ISSN
1432-119X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine enhances somatostatin receptor-
Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus
✍ M.N. Rodríguez-Sánchez; L. Puebla; S. López-Sañudo; E. Rodríguez-Martín; A. Mart 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Although there is evidence that suggests that dopamine (DA) has stimulatory effects on somatostatinergic transmission, it is unknown to date if DA increases the activity of the somatostatin (SS) receptor-effector system in the rat brain. In this study, we evaluated the effects of the administration

Chronic but not acute intracerebroventri
Chronic but not acute intracerebroventricular administration of amyloid β-peptide(25–35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity, and adenylate cyclase I levels in the rat hippocampus
✍ E. Burgos-Ramos; A. Hervás-Aguilar; L. Puebla-Jiménez; M.C. Boyano-Adánez; E. Ar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract Although alterations in adenylate cyclase (AC) activity and somatostatin (SRIF) receptor density have been reported in Alzheimer's disease, the effects of amyloid β‐peptide (Aβ) on these parameters in the hippocampus are unknown. Our aim was to investigate whether the peptide fragment A